Clinical References

National Guidelines

  1. National Kidney Foundation Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines
  2. Caring for Australians with Renal Impairment - Nutrition and Growth in Kidney Disease, Clinical Guidelines, Dec 2005
  3. 3. Foque, D et al. EBPG (European Best Practice Guidelines) Guideline on Nutrition. Nephrol Dial Transplant (2007) 22 [Suppl 2]: ii45 - ii87

Journals

  1. Mozaffarian, D. and Rimm, E. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006 Oct 18;296(15):1885-99
  2. Holick, M. Vitamin D Deficiency. N Engl J Med
  3. LaClair, R. et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005 Jun;45(6):1026-33
  4. Jones, G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3). Semin Dial. 2007 Jul-Aug;20(4):316-24
  5. Levin, A. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007 Jan;71(1):31-8. Epub 2006 Nov 8
  6. Vassalotti, JA. et al. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S56-68
  7. McCullough, PA, et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S38-45
  8. McFarlane, SI et al. Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S46-55
  9. Koury, MJ and Ponka, P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr. 2004;24:105-31
  10. Frank, T. Assessment of thiamine status in chronic renal failure patients , transplant recipients and hemodialysis patients receiving a multivitamin supplement. Int J Vit Nut Res 2000 July; 70 (4): 159-66
  11. Zachara B. Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review. Acta Biochim Pol 2006: 53(4) 663
  12. Yilmaz, M. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine Am J Kidney Dis. 2006 Jan;47(1):42-50
  13. Mydlik, M. Metabolism of Vitamin B6 and its requirement in chronic renal failure. Kidney Int, 1997 vol 52, suppl 62 S56-59
  14. Kopple, JD. Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int, 1981 May;19(5):694-704
  15. Lee, J. Omega-3 Fatty Acids for Cardioprotection. Mayo Clin Proc, 2008; 83 (3): 324-332
  16. Sekkarie, M. The Impact of over the counter Vitamin D supplements on Vitamin D and parathyroid hormone levels in chronic kidney disease. Clin Neph, 2006; 65 (2): 91-96
  17. Heaney, R. Vitamin D in Health and Disease. Clin J Am Soc Neph, 2008: 1535-1541
  18. Mann, JF. Effects of Vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study. Kidney Int, 2004 Apr; 65(4):1375-80
  19. Savica, V. Nutritional therapy in chronic kidney. Nutr Clin Care, 2005; 8:70-76
  20. Porrini, M. Thiamine, riboflavin, and pyridoxine status in chronic renal insufficiency. Int J Vitam Nutr Res. 1989; 59 (3): 304-8
  21. Wani, S. Acute tubular necrosis associated with chromium picolinate-containing dietary supplement. Ann Pharmacother. 2006 Mar;40(3):563-6. Epub 2006 Feb 21
  22. Cerulli, J. Chromium Picolinate toxicity. Ann Pharmacother. 1998 Apr;32(4):428-31
  23. de la Torre, A. Effect of age on vanadium nephrotoxicity in rats. Toxicol Lett. 1999 Mar 8;105(1):75-82
  24. Ravani, P. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. Kidney Int. 2009 Jan;75(1):88-95
  25. Reddi, AS. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats. Kidney Int 2001; 59:1342-1353
  26. Shah, SV. Oxidants in chronic kidney disease. J Am Soc Neph 2007; 18: 16-28
  27. Tokmak, F. et al. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant. 2008 Jul 1 (epub)
  28. Sesso, HD. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.. JAMA JAMA. 2008 Nov 12;300(18):2123-33
  29. Gaziano JM. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2009 Jan 7;301(1):52-62
  30. Rock, C. Multivitamin-multimineral supplements: who uses them. Am J Clin Nutr 2007; 85 (suppl) 277S
  31. Lonn, E et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005 Mar 16;293(11):1338-47
  32. Wasser, WG. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Int Med 1997 Mar 1;126(5):410.
  33. Domrose, U. Vitamins are associated with survival in patients with end-stage renal disease:a 4-year prospective study. Clin Neph 2007 67(4) 221
  34. Kopple JD. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000 Apr;57(4):1688-703.
  35. Ikizler TA. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol. 1995 Nov;6(5):1386-91
  36. Eustace JA. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004 Mar;65(3):1031-40
  37. Newman, V. Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. J Am Diet Assoc 1998 Mar;98(3):285-92.
  38. Wiygul, JB. Supplement use among men with prostate cancer. Urology. 2005 Jul;66(1):161-6.
  39. Qato, D. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300(24):2867-2878.
  40. Johnson, D. Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology (Carlton). 2007 Aug;12(4):321-30
  41. Druecke, T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant. 2001;16 Suppl 7:25-8
  42. Bischoff-Ferrari, H. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18 –28
  43. Chapuy, M. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327:1637
  44. Mahajan, S. Zinc in kidney disease. J Am Coll Nutr. 1989 Aug;8(4):296-304
  45. Zachara, B. Selenium and glutathione peroxidases in blood of patients with different stages of chronic renal failure. J Trace Elem Med Biol. 2004;17(4):291-9.
  46. Bonomini, M. Selenium in uremia: culprit or bystander? Nephron. 1992;60(4):385-9.
  47. Miller, E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46
  48. Omenn, GS. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996 Nov 6;88(21):1550-9.
  49. Feskanich, D. Vitamin A intake and hip fractures among postmenopausal women. JAMA. 2002 Jan 2;287(1):47-54.
  50. Bjelakovic, G. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet. 2004 Oct 2-8;364(9441):1219-28.
  51. Bonaa, K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578-1588.
  52. Jamison, R. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298:1163-1170
  53. Vora JP; Dolben J; Dean JD; Thomas D; Williams JD; Owens DR; Peters. JR Kidney Int 1992 Apr;41(4):829-35.
  54. Nowack R; Raum E; Blum W; Ritz E. Am J Kidney Dis 1992 Oct;20(4):342-7.
  55. Food and Drug Administration. CFSAN/Office of Nutritional Products, Labeling, and Dietary Supplements September 8, 2004; Docket No. 2003Q-0401.
  56. Bash, L. et al. Arch Intern Med 2008;168:2440-2447
  57. Elsayed, E et al. Arch Intern Med 2007; 167: 1130-1136
  58. Coresh, J et al. JAMA 2007 ; 298:2038-2047

General

  1. National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention
  2. United States Renal Data System 2008 Annual Data Report
  3. Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease - American Heart Association Scientific Statement

Textbooks

  1. Nutritional Management of Renal Disease, Kopple, J (ed) and Massry, S (ed). 2003
  2. Handbook of Nutrition and the Kidney, Fourth Ed. Mitch, W and Klahr, S.
  3. Council of Renal Nutrition Handbook, National Kidney Foundation
  4. Williams, S. Essentials of Nutrition and Diet Therapy. Elsevier Health Sciences, 2003
  5. Nutrition in Kidney Disease. Byham-Gray, L. Humana Press, 2008

 

Phone: 937-281-0123  |  Privacy  |  Terms & Conditions  |  Purchase Policy  |  ©2010 Nephroceuticals. All rights reserved. An IMXperts EOS360 Solution.